Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Pisters

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Chest|June 1, 1995
New chemotherapeutic agents for non-small cell lung cancerV A Miller, J R Rigas, S C Grant, et al.
Cancer|November 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapyL Baltzer, M G Kris, L B Tyson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trialsK M Pisters, M G Kris, R J Gralla, et al.
American Journal of Clinical Oncology|June 1, 1994
Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2L B Tyson, M G Kris, L Baltzer, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer|September 1, 1995
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicinL B Cleri, M G Kris, L B Tyson, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary reportJ S Lee, K M Pisters, R Komaki, et al.
Journal of Surgical Oncology|August 1, 1994
Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancerK M Pisters, M G Kris, R J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 1999
Oral cisapride for the control of delayed vomiting following high-dose cisplatinB A Pizzo, K M Pisters, V A Miller, et al.
Journal of Pain and Symptom Management|November 1, 1993
Midazolam in patients receiving anticancer chemotherapy and antiemeticsL M Potanovich, K M Pisters, M G Kris, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Chest|June 1, 1995
New chemotherapeutic agents for non-small cell lung cancerV A Miller, J R Rigas, S C Grant, et al.
Cancer|November 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapyL Baltzer, M G Kris, L B Tyson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trialsK M Pisters, M G Kris, R J Gralla, et al.
American Journal of Clinical Oncology|June 1, 1994
Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2L B Tyson, M G Kris, L Baltzer, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer|September 1, 1995
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicinL B Cleri, M G Kris, L B Tyson, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary reportJ S Lee, K M Pisters, R Komaki, et al.
Journal of Surgical Oncology|August 1, 1994
Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancerK M Pisters, M G Kris, R J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 1999
Oral cisapride for the control of delayed vomiting following high-dose cisplatinB A Pizzo, K M Pisters, V A Miller, et al.
Journal of Pain and Symptom Management|November 1, 1993
Midazolam in patients receiving anticancer chemotherapy and antiemeticsL M Potanovich, K M Pisters, M G Kris, et al.
Pageof 5